Korro Bio, Inc. Unrealized Gain (Loss) on Investments
Korro Bio, Inc. (KRRO) reported Unrealized Gain (Loss) on Investments of $553.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2025-11-12
- Korro Bio, Inc. unrealized gain (loss) on investments for the quarter ending 2024-09-30 was $553.00K.
- Korro Bio, Inc. unrealized gain (loss) on investments for the quarter ending 2024-06-30 was $21.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month |
|---|---|---|
| 2024-09-30 | $553.00K 10-Q · filed 2025-11-12 | $574.00K derived: sum of 2 quarters · filed 2025-11-12 |
| 2024-06-30 | $21.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |